Single User License
INR 169825
Site License
INR 339650
Corporate User License
INR 509475

Service Tax Additional

select a format
Price

Single User License
USD 2500
Site License
USD 5000
Corporate User License
USD 7500

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"

Ken Research completed the report successfully with tough deadline and large requirement. Really appreciate it... "Sales Manager, Largest India Aesthetic Laser Manufacturer"

We found the report really useful in understanding the complex Indian market and it provided lots of high quality insights. On the basis of this we commissioned Ken to produce a bespoke follow up to answer some specific questions about our market. This is now being used to help develop our marketing and sales strategy. We were very pleased with the comprehensive coverage, detail provided and actionable insights.... "Owner, Therefore Consulting UK"


Cirrhosis Global Clinical Trials Review, H1, 2015

Cirrhosis Global Clinical Trials Review, H1, 2015


  Request for Sample Report

Executive Summary

Cirrhosis Global Clinical Trials Review, H1, 2015

GlobalData's clinical trial report, "Cirrhosis Global Clinical Trials Review, H1, 2015" provides data on the Cirrhosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Cirrhosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Cirrhosis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each

Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type

Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons To Buy

Understand the dynamics of a particular indication in a condensed manner

Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more

Obtain discontinued trial listing for trials across the globe

Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Introduction 6

Cirrhosis 6

Report Guidance 6

Clinical Trials by Region 7

Clinical Trials and Average Enrollment by Country 8

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10

Top Five Countries Contributing to Clinical Trials in Europe 11

Top Countries Contributing to Clinical Trials in North America 12

Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13

Top Five Countries Contributing to Clinical Trials in Central and South America 14

Clinical Trials by G7 Countries: Proportion of Cirrhosis to Gastrointestinal Clinical Trials 15

Clinical Trials by Phase in G7 Countries 16

Clinical Trials in G7 Countries by Trial Status 17

Clinical Trials by E7 Countries: Proportion of Cirrhosis to Gastrointestinal Clinical Trials 18

Clinical Trials by Phase in E7 Countries 19

Clinical Trials in E7 Countries by Trial Status 20

Clinical Trials by Phase 21

In Progress Trials by Phase 22

Clinical Trials by Trial Status 23

Clinical Trials by End Point Status 24

Unaccomplished Trials of Cirrhosis 25

Subjects Recruited Over a Period of Time 29

Clinical Trials by Sponsor Type 30

Prominent Sponsors 31

Top Companies Participating in Cirrhosis Therapeutics Clinical Trials 32

Prominent Drugs 33

Latest Clinical Trials News on Cirrhosis 34

Nov 08, 2014: Phase 3 UNITY Trials Demonstrate High Cure Rates for Investigational, All-Oral Daclatasvir TRIO Fixed-Dose Combination in Genotype 1 Hepatitis C Patients, Including Those with Cirrhosis 34

Clinical Trial Profiles 35

Clinical Trial Overview of Top Companies 35

Merck & Co., Inc. 35

Clinical Trial Overview of Merck & Co., Inc. 35

Novartis AG 36

Clinical Trial Overview of Novartis AG 36

Genextra S.p.a. 37

Clinical Trial Overview of Genextra S.p.a. 37

GlaxoSmithKline plc 38

Clinical Trial Overview of GlaxoSmithKline plc 38

F. Hoffmann-La Roche Ltd. 39

Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 39

Zambon Company S.p.A. 40

Clinical Trial Overview of Zambon Company S.p.A. 40

Sanofi 41

Clinical Trial Overview of Sanofi 41

Otsuka Holdings Co., Ltd. 42

Clinical Trial Overview of Otsuka Holdings Co., Ltd. 42

AbbVie Inc. 43

Clinical Trial Overview of AbbVie Inc. 43

Pfizer Inc. 44

Clinical Trial Overview of Pfizer Inc. 44

Clinical Trial Overview of Top Institutes / Government 45

Hospital Clinic de Barcelona 45

Clinical Trial Overview of Hospital Clinic de Barcelona 45

The National Institute of Diabetes and Digestive and Kidney Diseases 46

Clinical Trial Overview of The National Institute of Diabetes and Digestive and Kidney Diseases 46

Assistance Publique-Hopitaux de Paris 47

Clinical Trial Overview of Assistance Publique-Hopitaux de Paris 47

Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran 48

Clinical Trial Overview of Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran 48

Govind Ballabh Pant Hospital 49

Clinical Trial Overview of Govind Ballabh Pant Hospital 49

Institute of Liver and Biliary Sciences 50

Clinical Trial Overview of Institute of Liver and Biliary Sciences 50

Sun Yat-sen University 51

Clinical Trial Overview of Sun Yat-sen University 51

Beijing Friendship Hospital 52

Clinical Trial Overview of Beijing Friendship Hospital 52

Mayo Clinic 53

Clinical Trial Overview of Mayo Clinic 53

Fundacio Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 54

Clinical Trial Overview of Fundacio Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 54

Five Key Clinical Profiles 55

Appendix 115

Abbreviations 115

Definitions 115

Research Methodology 116

Secondary Research 116

About GlobalData 117

Contact Us 117

Disclaimer 117

Source 118

List of Figures

Cirrhosis Therapeutics, Global, Clinical Trials by Region (%), 2015* 7

Cirrhosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Cirrhosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Cirrhosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10

Cirrhosis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11

Cirrhosis Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12

Cirrhosis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2015* 13

Cirrhosis Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2015* 14

Proportion of Cirrhosis to Gastrointestinal Clinical Trials, G7 Countries (%), 2015* 15

Cirrhosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Cirrhosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Cirrhosis to Gastrointestinal Clinical Trials, E7 Countries (%), 2015* 18

Cirrhosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Cirrhosis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Cirrhosis Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21

Cirrhosis Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22

Cirrhosis Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Cirrhosis Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24

Cirrhosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 29

Cirrhosis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 30

Cirrhosis Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 31

Cirrhosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 32

Cirrhosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 33

GlobalData Methodology 116

List of Tables

Cirrhosis Therapeutics, Global, Clinical Trials by Region, 2015* 7

Cirrhosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Cirrhosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Cirrhosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10

Cirrhosis Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11

Cirrhosis Therapeutics Clinical Trials, North America, Top Countries, 2015* 12

Cirrhosis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2015* 13

Cirrhosis Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2015* 14

Proportion of Cirrhosis to Gastrointestinal Clinical Trials, G7 Countries (%), 2015* 15

Cirrhosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Cirrhosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Cirrhosis to Gastrointestinal Clinical Trials, E7 Countries (%), 2015* 18

Cirrhosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Cirrhosis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Cirrhosis Therapeutics, Global, Clinical Trials by Phase, 2015* 21

Cirrhosis Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22

Cirrhosis Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Cirrhosis Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24

Cirrhosis Therapeutics, Global, Suspended Clinical Trials, 2015* 25

Cirrhosis Therapeutics, Global, Withdrawn Clinical Trials, 2015* 26

Cirrhosis Therapeutics, Global, Terminated Clinical Trials, 2015* 27

Cirrhosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 29

Cirrhosis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 30

Cirrhosis Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 31

Cirrhosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 32

Cirrhosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 33

Cirrhosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2015* 35

Cirrhosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015* 36

Cirrhosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Genextra S.p.a., 2015* 37

Cirrhosis Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2015* 38

Cirrhosis Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2015* 39

Cirrhosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Zambon Company S.p.A., 2015* 40

Cirrhosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2015* 41

Cirrhosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Otsuka Holdings Co., Ltd., 2015* 42

Cirrhosis Therapeutics Clinical Trials Market, Global, Clinical Trials by AbbVie Inc., 2015* 43

Cirrhosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015* 44

Cirrhosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Hospital Clinic de Barcelona, 2015* 45

Cirrhosis Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Diabetes and Digestive and Kidney Diseases, 2015* 46

Cirrhosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique-Hopitaux de Paris, 2015* 47

Cirrhosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, 2015* 48

Cirrhosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Govind Ballabh Pant Hospital, 2015* 49

Cirrhosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Institute of Liver and Biliary Sciences, 2015* 50

Cirrhosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Sun Yat-sen University, 2015* 51

Cirrhosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Beijing Friendship Hospital, 2015* 52

Cirrhosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2015* 53

Cirrhosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Fundacio Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau, 2015* 54

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Cirrhosis Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Cirrhosis, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.


Related Products in vertical
Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com